Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

No trades
See on Supercharts

Price target

8.000.000.00%
The 1 analyst offering 1 year price forecasts for ATXI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to ATXI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ATXI EPS for the last quarter is −1.92 USD despite the estimation of −0.94 USD. In the next quarter EPS is expected to reach −0.57 USD. Track more of Avenue Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, ATXI price target is 8.00 USD with a max estimate of 8.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Avenue Therapeutics, Inc. stock price chart and keep track of the current situation with ATXI news and stock market news.